Signal Tree Financial Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Buy
2,105
+2
+0.1% +$430 0.35% 28
2026
Q1
$457K Sell
2,103
-2
-0.1% -$444 0.35% 28
2025
Q4
$481K Sell
2,105
-90
-4% -$20.5K 0.37% 30
2025
Q3
$536K Hold
2,195
0.42% 30
2025
Q2
$407K Sell
2,195
-14
-0.6% -$2.6K 0.35% 30
2025
Q1
$463K Sell
2,209
-91
-4% -$17.7K 0.46% 25
2024
Q4
$409K Buy
+2,300
New +$423K 0.48% 26

Other funds holding ABBV

Signal Tree Financial Partners's ABBV Position: Q2 2026 in Review

Signal Tree Financial Partners increased its AbbVie (ABBV) stake by 0.1% in Q2 2026, buying an estimated $430 and bringing the position to 2,105 shares worth $530K. The position accounts for 0.35% of the portfolio, ranked #28.

Signal Tree Financial Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $536K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Signal Tree Financial Partners held 2,105 shares of AbbVie worth $530K as of Q2 2026.
  • Signal Tree Financial Partners bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.35% of Signal Tree Financial Partners's portfolio in Q2 2026, its #28 holding.
  • Signal Tree Financial Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Signal Tree Financial Partners's AbbVie position peaked at $536K in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Signal Tree Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.